MIT chemical engineers have developed a new sensor that lets them see inside cancer cells and determine whether the cells are responding to a particular type of chemotherapy drug.
The sensors, which detect hydrogen peroxide inside human cells, could help researchers identify new cancer drugs that boost levels of hydrogen peroxide, which induces programmed cell death. The sensors could also be adapted to screen individual patients’ tumors to predict whether such drugs would be effective against them.
“The same therapy isn’t going to work against all tumors,” says Hadley Sikes, an associate professor of chemical engineering at MIT. “Currently there’s a real dearth of quantitative, chemically specific tools to be able to measure the changes that occur in tumor cells versus normal cells in response to drug treatment.”
Sikes is the senior author of the study, which appears in the Aug. 7 issue of Nature Communications. The paper’s first author is graduate student Troy Langford; other authors are former graduate students Beijing Huang and Joseph Lim and graduate student Sun Jin Moon.
Tracking hydrogen peroxide
Cancer cells often have mutations that cause their metabolism to go awry and produce abnormally high fluxes of hydrogen peroxide. When too much of the molecule is produced, it can damage cells, so cancer cells become highly dependent on antioxidant systems that remove hydrogen peroxide from cells.
Drugs that target this vulnerability, which are known as “redox drugs,” can work by either disabling the antioxidant systems or further boosting production of hydrogen peroxide. Many such drugs have entered clinical trials, with mixed results.
“One of the problems is that the clinical trials usually find that they work for some patients and they don’t work for other patients,” Sikes says. “We really need tools to be able to do more well-designed trials where we figure out which patients are going to respond to this approach and which aren’t, so more of these drugs can be approved.”
To help move toward that goal, Sikes set out to design a sensor that could sensitively detect hydrogen peroxide inside human cells, allowing scientists to measure a cell’s response to such drugs.
Existing hydrogen peroxide sensors are based on proteins called transcription factors, taken from microbes and engineered to fluoresce when they react with hydrogen peroxide. Sikes and her colleagues tried to use these in human cells but found that they were not sensitive in the range of hydrogen peroxide they were trying to detect, which led them to seek human proteins that could perform the task.
Through studies of the network of human proteins that become oxidized with increasing hydrogen peroxide, the researchers identified an enzyme called peroxiredoxin that dominates most human cells’ reactions with the molecule. One of this enzyme’s many functions is sensing changes in hydrogen peroxide levels.
Langford then modified the protein by adding two fluorescent molecules to it — a green fluorescent protein at one end and a red fluorescent protein at the other end. When the sensor reacts with hydrogen peroxide, its shape changes, bringing the two fluorescent proteins closer together. The researchers can detect whether this shift has occurred by shining green light onto the cells: If no hydrogen peroxide has been detected, the glow remains green; if hydrogen peroxide is present, the sensor glows red instead.
The researchers tested their new sensor in two types of human cancer cells: one set that they knew was susceptible to a redox drug called piperlongumine, and another that they knew was not susceptible. The sensor revealed that hydrogen peroxide levels were unchanged in the resistant cells but went up in the susceptible cells, as the researchers expected.
Sikes envisions two major uses for this sensor. One is to screen libraries of existing drugs, or compounds that could potentially be used as drugs, to determine if they have the desired effect of increasing hydrogen peroxide concentration in cancer cells. Another potential use is to screen patients before they receive such drugs, to see if the drugs will be successful against each patient’s tumor. Sikes is now pursuing both of these approaches.
“You have to know which cancer drugs work in this way, and then which tumors are going to respond,” she says. “Those are two separate but related problems that both need to be solved for this approach to have practical impact in the clinic.”
The Latest on: Cancer therapy
via Google News
The Latest on: Cancer therapy
- Mum with stage 4 cancer refused lifeline treatment as family slam heartbreaking NHS postcode lotteryon July 25, 2021 at 12:04 am
A mum who was told she has incurable bowel cancer has been refused lifeline NHS treatment because of a "Russian roulette" postcode lottery. At just 40-years-old Lucy Laidlaw was given the devastating ...
- Anti-Mask Protester Punches Masked Cancer Patient in Front of Medical Clinic (VIDEO)on July 24, 2021 at 3:44 pm
An anti-mask protester in California is under fire after she was caught on video hitting a breast cancer patient in the chest outside of a California treatment center. The post Anti-Mask Protester ...
- Hingham Teen Finishes His Last Cancer Treatment, Sets Up Lemonade Stand For The Jimmy Fundon July 24, 2021 at 12:22 pm
A lemonade stand in Hingham was raising money for a special cause on Saturday. It was run by 13-year-old Jeremy, who finished his last cancer treatment in March. He wants all of the proceeds to go to ...
- Using Group Therapy as a Learning Experience for Patients With Canceron July 24, 2021 at 8:00 am
A patient with cancer recalls his experience with group therapy started by a nurse that helped him learn more not only from her but from others in similar situations.
- Nomograms May Aid Patient Selection for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Canceron July 23, 2021 at 8:00 am
New nomograms may predict outcomes of lutetium-177 prostate-specific membrane antigen treatment in metastatic castration-resistant prostate cancer.
- Novel imaging agent identifies biomarker for iron-targeted cancer therapieson July 23, 2021 at 7:37 am
A new radiotracer that detects iron in cancer cells has proven effective, opening the door for the advancement of iron-targeted therapies for cancer patients. The radiotracer, 18F-TRX, can be used to ...
- Pancreatic Cancer Treatment Market: Global Size Trends, Sales Revenue, Growth, Share and Growth Factor Analysis Research Report 2026on July 21, 2021 at 10:06 pm
The global Pancreatic Cancer Treatment Market size is expected to rise substantially owing to increasing consumption of ...
- Inner Banks: Outer Banks hospital brings holistic complementary therapy to cancer uniton July 21, 2021 at 2:24 pm
Donna Cahill, a nurse from San Diego, practiced healing touch therapy with patients at her hospital for about 20 years before retiring to the Outer Banks in September of 2018.
- Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast canceron July 20, 2021 at 7:04 pm
A research team led by Fumito Ito, MD, PhD, FACS, of Roswell Park Comprehensive Cancer Center reports new data on the promise of combining standard treatment for breast cancer with a particular form ...
via Bing News